https://www.selleckchem.com/pr....oducts/zidesamtinib.
05). Three months after surgery, the favorable prognosis rate in the endoscopic treatment group was significantly higher than that in the craniotomy group [83.3% (28/34) vs. 61.5% (31/51), respectively; χ2 = 4.698, P = 0.030]. In contrast, no significant differences in rebleeding, pulmonary infection, tracheotomy, secondary epilepsy, gastrointestinal hemorrhage, death in late postoperative period, or in baseline parameters were observed between the two groups (P 0.05). Conclusion Endoscopic surgery potentially represents a benefici
Like
Comment
Share
